Core Points - Stakeholder Gold Corporation has conditionally approved a private placement offering size of up to $3,000,000 or 3,750,000 units [1] Group 1 - The private placement is part of the company's strategy to raise funds for future activities [1] - The offering is expected to enhance the company's financial position and support its operational plans [1] Group 2 - The news release contains forward-looking information regarding the company's future financial and operational performance [2][3] - The forward-looking statements are based on current expectations and are subject to various risks and uncertainties [3][4]

Toronto, Ontario--(Newsfile Corp. - September 3, 2025) - Stakeholder Gold Corp. (TSXV: SRC) (OTC Pink: SKHRF) (WKN: A2QEP1) ("Stakeholder" or the "Company") is pleased to report a gross margin of 76.9% on quartzite sales of $911,837 CAD in H1.2025. Revenues increased by 153% over the year from $359,908 CAD in H1.2024 to $911,837 CAD in H1.2025, and by 38% on the quarter from $383,911 CAD in Q1.2025 to $527,926 CAD in Q2.2025. Quartzite sales in Brazil are recovering quickly in a trend which the Company now ...

Core Viewpoint - Stakeholder Gold Corp. has initiated its 2025 exploration program on the Ballarat Gold-Copper Project, focusing on diamond drilling in the Skye Gold Zone and Loki Copper Zone to confirm mineralization and grade [1][10][11]. Exploration Program Details - The company plans to drill a total of 1,600 meters across 8 drill holes, with approximately 1,200 meters targeting the Skye Gold Zone and 400 meters for the Loki Copper Zone [2]. - The exploration will also include geological mapping and prospecting in addition to drilling activities [2]. Skye Gold Zone - The Skye Gold Zone features two subparallel gold in soil trends measuring 1.9 km and 1.3 km, associated with ENE oriented structures [3]. - Initial drilling will focus on the strongest gold in soil anomalies along the northern portion of the trend, with up to 6 holes planned to test a combined strike length of 200 meters [4]. Loki Copper Zone - The Loki Copper Zone is located approximately 7.5 km southeast of the Skye Gold Zone and has a 2.3 km x 530 m anomalous copper in soils signature [5]. - Initial drilling will consist of 2 holes designed to intersect the copper in soil anomaly and the associated intrusive unit [6]. Strategic Importance - The company aims to confirm two new discoveries in 2025, which could significantly enhance its understanding of the mineralogical potential of the identified gold and copper trends [10][11]. - The geological targets are strategically located on either side of the planned Resource Gateway Road, which is expected to traverse nearly 17 km through the company's claims [11]. Property Overview - Stakeholder Gold Corp. holds a 100% ownership of an 18,741-hectare contiguous claim position in the White Gold District, strategically located near other significant projects [12].

Core Viewpoint - Stakeholder Gold Corp. has submitted a Class 1 Notification for 2025 exploration on the Ballarat Gold-Copper Project, which includes maiden drilling on the Skye Gold Zone and the Loki Copper Zone [1][5]. Exploration Program Details - The company plans to drill 2,500 meters over 8 to 10 drill holes, targeting the Skye Gold Zone and the Loki Copper Zone, which are approximately 8 to 10 km apart [2]. - Approximately 2,000 meters of drilling is expected on the Skye Gold Zone and 500 meters on the Loki Copper Zone, aimed at confirming structural controls, mineralization, and grade [2]. - Additional exploration activities for 2025 will include expanded soil grid surveys, geological mapping, prospecting, and a LiDAR survey [2]. Strategic Objectives - The objective is to announce results confirming new discoveries for both the Skye Gold Zone and the Loki Copper Zone during the 2025 summer exploration season [5]. - The year 2025 is anticipated to be pivotal for the company in understanding the mineralogical potential of the identified gold and copper structures [5]. Future Implications - If drilling results confirm mineralization and grade as expected, it may lead to a robust follow-up program for definition drilling on both targets [6].

Core Insights - Stakeholder Gold Corp. has commenced sales from its third quarry in Minas Gerais, Brazil, producing white quartzite blocks for international clients [1][4] - The quarry is expected to meet a market demand for high-quality white quartzite, with several buyers already expressing interest [2][5] - The project received commercialization approval from the Agencia Nacional de Mineração (ANM) on December 16, 2024, with production startup delayed due to heavy rains [3] Production and Sales - The quarry aims to produce at least 40 cubic meters of material for sale as blocks and 20 cubic meters for polished slabs, equating to approximately 8,000 square feet [5] - Sales from the first quarry have been strong, with buyers reporting depleting inventory and expected growth in sales through the first half of 2025 [6] Strategic Outlook - The expansion of cash flow from the exotic stone business in Brazil will support the company's gold and copper exploration initiatives in the Yukon Territory, aiming for minimal shareholder dilution [7]

Core Viewpoint - Stakeholder Gold Corp. has announced positive results from the VLF-EM geophysical survey conducted on its Ballarat Gold-Copper Project, indicating significant potential for gold and copper mineralization in the White Gold District of Yukon Territory, Canada [1][2]. Exploration Program - The 2024 exploration program included a ground-based VLF-EM survey on the Skye Gold Zone, grid soil sampling on the Loki Copper Zone, and a drone magnetic survey across the property [2][3]. - The VLF-EM survey was specifically aimed at aiding structural interpretation within the Skye Gold Zone, covering a total of 2.5 line-km [4][5]. Survey Results - The VLF-EM survey revealed a strong correlation between surface gold zones, interpreted structures from the magnetic survey, and low-resistivity zones, which are believed to be primary structural controls for gold mineralization [6]. - Newly defined structural targets in the Skye Gold Zone are now prioritized for drilling in 2025, with follow-up work planned for gold in soil anomalies in the East Zone, located approximately 2 km east of the Skye Gold Zone [7]. Size Potential - The Skye Gold Zone is characterized by two sub-parallel features extending 1.9 km and 1.3 km, respectively, with enhanced exploration merit for the East Zone due to revised structural interpretations [10]. - The exploration work in 2024 has confirmed the size potential for both the Skye Gold Zone and the Loki Copper Zone, which are strategically located near the planned Northern Gateway Road [10]. Future Plans - The company is considering a 2025 exploration season plan that includes up to 2,500 m of drilling, with 8-10 holes on the Skye Gold Zone and 1-2 holes on the Loki Copper Zone, along with expanded soil sampling and geophysical surveys [11]. Property Overview - The Ballarat Property encompasses 18,741 hectares and is situated in a key area of the White Gold District, adjacent to significant projects owned by major mining companies [12].

Company Operations - Stakeholder Gold Corp. has commenced operations at its third quarry in Minas Gerais, Brazil, which will produce white quartzite blocks for cutting and polishing into saleable slabs [1][2] - The quarry is expected to ramp up production quickly, with an anticipated output of 250 cubic meters per month to meet client demand [3][2] - The first test block is currently being produced and will be available for client review by mid-December [3] Production and Financial Outlook - The breakeven sales volume for the quarry is estimated at 30 cubic meters per month, while the first quarry sold approximately 130 cubic meters of blue quartzite in October 2024 [5] - The company expects to return to profitability in Q4 2024, bolstered by the opening of two new quarries, bringing the total to three operating quarries by the end of 2024 [5] - VMC sales in October 2024 reached a new high of USD 200,000, indicating a strengthening market for Brazilian dimensional stone [7] Strategic Initiatives - The cash flow generated from the quartzite business will support minimally dilutive exploration initiatives in the Yukon Territory, Canada, focusing on gold and copper [6] - The company aims to maximize prospective share price performance for shareholders through successful advancement of its exploration initiatives [6]

Core Insights - Pasithea Therapeutics has received a recommendation from the external Safety Review Committee to escalate the trial to the next dose level of 15mg capsule due to the absence of dose-limiting toxicities and rashes observed in the initial patients [1][2] - The Phase 1 clinical trial is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of PAS-004 in patients with advanced solid tumors driven by the MAPK pathway [2][3] - PAS-004 is differentiated from first-generation MEK inhibitors by its potential for once-daily dosing and a long half-life of approximately 70 hours, which may reduce toxicity risks [3] Company Overview - Pasithea Therapeutics is focused on developing innovative treatments for central nervous system disorders and RASopathies, with a team experienced in neuroscience, translational medicine, and drug development [4]

Core Viewpoint - Stakeholder Gold Corp. is celebrating Klondike Gold Discovery Day, highlighting the historical significance of gold discoveries in the Yukon Territory and the ongoing exploration efforts in the White Gold District [1][11]. Historical Context - The Yukon Gold Rush began on August 16, 1896, when gold was discovered on Rabbit Creek, leading to a massive influx of prospectors and the establishment of Dawson City as a booming center for gold [2][3]. - Klondike Gold Discovery Day was established as a holiday in 1911 to commemorate the gold rush and its impact on the region [3]. Current Exploration and Discoveries - The 21st century has seen a resurgence in gold exploration in the Klondike, with new hard rock sources being discovered that may exceed the estimated 16+ million ounces of placer gold previously recovered [4]. - Stakeholder Gold Corp. holds 100% ownership of an 18,741-hectare claim position in the White Gold District, focusing on the Ballarat Creek area, known for its prolific placer gold production [9][10]. - Recent exploration efforts have identified two distinct gold trends in the Skye Zone, measuring 1.9 km and 1.3 km, which are now the focus of follow-up exploration in 2024 [10]. Industry Outlook - The White Gold District is recognized as one of the largest gold area plays in Western Canada, with optimism surrounding the potential for additional hard rock gold deposits to be discovered [8]. - Stakeholder Gold Corp. aims to deliver economically significant gold discoveries in the White Gold District, with ongoing exploration initiatives designed to achieve this goal [12].

Core Insights - Aprea Therapeutics is advancing its clinical trial for ATRN-119, a macrocyclic ATR inhibitor, with the goal of generating initial human efficacy data in the second half of 2024 [1][2] - The Safety Review Committee has approved the commencement of dosing at 800 mg once daily, indicating positive progress in the trial [2][3] - Preliminary signs of clinical benefit have been observed in two patients, with stable disease reported [4] Clinical Trial Progress - The ABOYA-119 trial is a Phase 1/2a multi-center, open-label, dose-escalation study focusing on patients with advanced solid tumors and specific mutations in DDR pathways [2][6] - A total of 17 patients have been enrolled across five cohorts, with dosing levels ranging from 50 mg to 550 mg once daily [3] - An amendment for additional cohorts at 1100 mg and 1300 mg has been submitted to the FDA, aiming for a total of eight cohorts [3] Efficacy and Safety Data - Pharmacokinetic data indicate that systemic exposure increases with each dose level, with therapeutic plasma concentrations achieved at doses of 550 mg and above [2][7] - Initial efficacy data from Part 1 of the study is expected to be announced in the second half of 2024, with the completion of dose escalation anticipated by the fourth quarter of 2024 [5] - The recommended Phase 2 dose is expected to be determined in the first quarter of 2025, with enrollment for the Phase 2a cohort beginning shortly thereafter [5] Company Overview - Aprea Therapeutics is focused on precision oncology through synthetic lethality, with ATRN-119 being its lead program targeting solid tumors [8] - The company has completed all IND enabling studies for its oral WEE1 inhibitor, APR-1051, and has received FDA clearance for its IND [8]